Retirement Systems of Alabama Has $25.47 Million Stock Holdings in Encompass Health Co. (NYSE:EHC)

Retirement Systems of Alabama boosted its holdings in Encompass Health Co. (NYSE:EHC) by 0.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 275,804 shares of the company’s stock after buying an additional 268 shares during the quarter. Retirement Systems of Alabama’s holdings in Encompass Health were worth $25,470,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. Truist Financial Corp lifted its holdings in shares of Encompass Health by 1.1% during the second quarter. Truist Financial Corp now owns 19,338 shares of the company’s stock worth $1,659,000 after purchasing an additional 205 shares during the period. Cetera Investment Advisers lifted its holdings in Encompass Health by 5.7% during the 2nd quarter. Cetera Investment Advisers now owns 12,353 shares of the company’s stock worth $1,060,000 after buying an additional 664 shares during the period. Sanctuary Advisors LLC bought a new stake in shares of Encompass Health in the 2nd quarter valued at about $1,384,000. Handelsbanken Fonder AB increased its stake in shares of Encompass Health by 16.2% in the third quarter. Handelsbanken Fonder AB now owns 24,353 shares of the company’s stock valued at $2,353,000 after buying an additional 3,400 shares during the period. Finally, GAMMA Investing LLC raised its position in shares of Encompass Health by 34.7% during the third quarter. GAMMA Investing LLC now owns 1,595 shares of the company’s stock worth $154,000 after acquiring an additional 411 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Price Performance

EHC stock opened at $102.18 on Thursday. Encompass Health Co. has a 1 year low of $71.79 and a 1 year high of $104.55. The stock has a market capitalization of $10.29 billion, a PE ratio of 24.68, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90. The company’s 50-day moving average is $96.43 and its 200-day moving average is $95.08. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. KeyCorp upped their target price on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Barclays increased their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Royal Bank of Canada boosted their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Finally, Truist Financial reiterated a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.